From the Guidelines
COVID-19 statistics for 2025 are not currently available, and any information would be speculative as of the last update in 2024. The most recent data and recommendations are based on the 2024-2025 COVID-19 vaccination guidelines, which suggest the use of vaccines for persons aged ≥6 months to provide protection against severe COVID-19–associated illness and death 1. As of the last update, SARS-CoV-2 continues to evolve, with Omicron JN.1 lineage strains, including the JN.1 strain and the KP.2 strain, widely circulating in the United States.
The current recommendations for COVID-19 vaccination are based on the Advisory Committee on Immunization Practices (ACIP) guidelines, which were updated on June 27,2024, to recommend 2024–2025 COVID-19 vaccination with a Food and Drug Administration (FDA)–approved or authorized vaccine for all persons aged ≥6 months 1. The FDA has approved the 2024–2025 COVID-19 vaccines by Moderna and Pfizer-BioNTech (based on the KP.2 strain) for use in persons aged ≥12 years and authorized these vaccines for use in children aged 6 months–11 years under Emergency Use Authorization (EUA) 1.
For the most current and accurate COVID-19 statistics, it is essential to consult official public health websites, such as the WHO or CDC, which provide real-time or recent historical data rather than looking for statistics from future years. These organizations will collect and publish COVID-19 statistics for 2025 once that year occurs and the data becomes available, including metrics such as:
- Case numbers
- Hospitalizations
- Deaths
- Vaccination rates
- Variant prevalence
The nature of infectious diseases makes long-term predictions challenging due to factors like viral mutations, vaccination coverage changes, and evolving public health measures 1. Therefore, relying on the most recent and authoritative sources for COVID-19 information is crucial for making informed decisions.
From the FDA Drug Label
The FDA drug label does not answer the question.
From the Research
Current Coronavirus (COVID-19) Statistics
There are no research papers provided that contain the current Coronavirus (COVID-19) statistics for 2025. The studies available are from 2022,2023, and 2024, and they focus on various aspects of COVID-19, such as treatment strategies, vaccine efficacy, and antiviral medications.
Available Data
- The studies provided do not include real-time data or statistics on COVID-19 cases, hospitalizations, or deaths for 2025 2, 3, 4, 5, 6.
- The available data is limited to the study periods, which are prior to 2025.
- The studies discuss the efficacy of various treatments, vaccines, and antiviral medications, but do not provide current statistics on COVID-19 cases or outcomes.
Key Findings
- The studies highlight the importance of vaccination and antiviral treatments in preventing severe COVID-19 outcomes 3, 4, 5.
- The efficacy of bivalent vaccines and nirmatrelvir-ritonavir in preventing hospitalizations and deaths is discussed in the studies 3, 4, 5.
- The studies also mention the need for continued research and development of effective treatments and vaccines against COVID-19 2, 6.